Cooley advised Cellares on the fundraising. Cellares has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya on the fundraising. Kriya Therapeutics, Inc. announced the addition of over $150 million in capital committed as part of its Series C Financing,...
You must be a Standard 1 Year member to access this content.
Cooley advised Kriya Therapeutics on the deal. Kriya Therapeutics, a fully integrated gene therapy company pioneering novel technologies and therapeutics, announced its $270 Million Series C financing...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised ClickUp on the deal. ClickUp, a workplace productivity company, announced its $400 million Series C financing, which brings its valuation to $4 billion. Andreessen...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
You must be a Standard 1 Year member to access this content.
